| 1188 |
Centers for Disease Control and Prevention |
Html |
en |
Progress Toward Measles Elimination - Eastern MediterraneanRegion, 2008-2012 |
Nadia Teleb, MD1, Emmaculate Lebo, MBChB2, Hinda Ahmed, PhD1, Abdel Rahman Hossam1, El Tayeb El Sayed, MD1, Alya Dabbagh, PhD3, Peter Strebel, MBBS3, Paul Rota, PhD4, James Alexander, MD2 (Author affiliations at end of text). |
| measles vaccination schedules | 0.580376 |
| Gaza Strip | 0.38471 |
| 2-dose vaccination coverage | 0.411124 |
| measles elimination | 0.851315 |
| measles incidence | 0.634839 |
| vaccination coverage | 0.524842 |
| measles outbreaks | 0.551956 |
| MCV1 coverage | 0.469635 |
| measles mortality | 0.507656 |
| measles virus | 0.552036 |
| routine immunization services | 0.433595 |
| South Sudan | 0.485025 |
| endemic measles | 0.540827 |
| Rubella Laboratory Network | 0.451111 |
| measles susceptibility | 0.498152 |
| measles elimination activities | 0.544237 |
| measles virus isolation | 0.540906 |
| routine 2-dose coverage | 0.383157 |
| EMR measles cases | 0.618153 |
| nationwide measles | 0.520885 |
| emr measles | 0.619207 |
| measles case-based surveillance | 0.725839 |
| routine 2-dose vaccination | 0.406709 |
| vaccination services | 0.41302 |
| Global Measles | 0.532508 |
|
| surveillance performance indicators | 0.423733 |
| measles cases | 0.743783 |
| measles elimination goal | 0.595162 |
| routine vaccination services | 0.389238 |
| West Bank | 0.386474 |
| Large measles outbreaks | 0.548094 |
| Eastern Mediterranean Region | 0.417869 |
| MCV2 vaccination coverage | 0.39416 |
| measles vaccine | 0.522085 |
| Routine MCV1 coverage | 0.391307 |
| nationwide catch-up SIAs | 0.390458 |
| high incidence | 0.410542 |
| measles virus genotype | 0.539418 |
| administrative coverage | 0.403432 |
| endemic measles cases | 0.538272 |
| EMR countries | 0.770577 |
| national case-based surveillance | 0.395645 |
| case-based surveillance performance | 0.438015 |
| endemic measles transmission | 0.527958 |
| subsequent measles outbreaks | 0.53488 |
| follow-up sias | 0.413392 |
| follow-up SIAs target | 0.396233 |
| measles | 0.969846 |
| complete measles | 0.497807 |
|
CLICK HERE |
| 4863 |
Centers for Disease Control and Prevention |
Html |
en |
2009 H1N1: Overview of a Pandemic - 508 Accessible version |
null |
| H1N1 virus | 0.578075 |
| website | 0.36414 |
| stand-alone Web document | 0.729758 |
| CDC Seasonal Flu | 0.865237 |
| information | 0.361508 |
| reference purposes | 0.542622 |
|
| page | 0.337161 |
| PowerPoint presentation | 0.533989 |
| pandemic | 0.4653 |
| human flu virus | 0.931057 |
| Section 508-accessible version | 0.69968 |
|
CLICK HERE |
| 6489 |
Centers for Disease Control and Prevention |
Html |
en |
Restricting unhealthful food advertising to children and the First Amendment [letter |
In their recent article, Harris and Graff describe ways that local governments can restrict the marketing of unhealthful food to children, including limiting store displays and banning commercial billboards. |
| Human Services | 0.477344 |
| specific local policies | 0.555833 |
| jurisprudence states | 0.476519 |
| commercial speech | 0.838872 |
| local governments | 0.760954 |
| stronger rationale | 0.488661 |
| U.S. Department | 0.477413 |
| legitimate exercise | 0.490438 |
| Disease Control | 0.475501 |
| children | 0.582559 |
| persuasive speech | 0.49433 |
| unhealthful food | 0.993253 |
| child-centered environments | 0.484542 |
| food advertising | 0.487699 |
| public’s health | 0.485632 |
| esthetics | 0.465824 |
| Hopkins Bloomberg School | 0.543103 |
| proposed restrictions | 0.480682 |
| Substantial evidence document | 0.554381 |
| recreation centers | 0.475913 |
| police powers | 0.481158 |
| tobacco advertisements | 0.474755 |
| reasonable fit | 0.479299 |
| commercial speech cases | 0.572528 |
| substantial government | 0.491633 |
|
| store displays | 0.49327 |
| schools | 0.444469 |
| affiliated institutions | 0.477069 |
| constitutional standards | 0.475712 |
| authors | 0.441713 |
| recent article | 0.49571 |
| true intent | 0.493776 |
| fine line | 0.478554 |
| potential First Amendment | 0.496557 |
| police power | 0.49112 |
| traffic safety | 0.49422 |
| negative health effects | 0.5507 |
| store window clutter | 0.569096 |
| stipulation | 0.516459 |
| stated rationales | 0.499215 |
| Central Hudson test | 0.842851 |
| Lauren M. Rossen | 0.540322 |
| commercial billboards | 0.512613 |
| visual clutter | 0.511301 |
| lawful product | 0.481175 |
| Supreme Court | 0.642375 |
| Public Health Service | 0.541542 |
| childhood obesity | 0.480604 |
| non–speech-related considerations | 0.492959 |
|
CLICK HERE |
| 7009 |
Centers for Disease Control and Prevention |
Html |
en |
Section 901 of the Federal Food, Drug, and Cosmetic Act -FDA Authority over Tobacco Products |
null |
| United States Code | 0.332872 |
| agency centers | 0.270816 |
| possession | 0.215156 |
| Tobacco Control Act | 0.727627 |
| Procedures | 0.214608 |
| section | 0.230942 |
| tobacco grower cooperatives | 0.497637 |
| tobacco | 0.914894 |
| Applicability. | 0.215931 |
| tobacco growers | 0.43367 |
| order | 0.216098 |
| tobacco product manufacturers | 0.578774 |
| Construction | 0.214577 |
| enactment | 0.216122 |
| sections | 0.214837 |
| tobacco products | 0.738965 |
| roll-your-own tobacco | 0.465241 |
| provisions | 0.260828 |
| related matters | 0.270161 |
| identifiable office | 0.273036 |
| Federal agencies | 0.271282 |
| producer | 0.300037 |
| General | 0.254938 |
| manufacturing process | 0.275592 |
| cigarettes | 0.215476 |
|
| risk tobacco products | 0.537022 |
| Family Smoking Prevention | 0.606554 |
| chapter | 0.481859 |
| subsection | 0.215392 |
| Secretary | 0.372816 |
| regulation deems | 0.288054 |
| production | 0.225242 |
| tobacco product manufacturer | 0.669731 |
| Secretary authority | 0.299442 |
| Drug Administration | 0.474508 |
| written consent | 0.278517 |
| title | 0.236878 |
| Food | 0.270148 |
| policy | 0.214861 |
| tobacco product | 0.674915 |
| cigarette tobacco | 0.460077 |
| Exception. Notwithstanding subparagraph | 0.342308 |
| accordance | 0.235772 |
| Commissioner | 0.230317 |
| nonfinancial assistance | 0.272613 |
| small tobacco product | 0.578849 |
| smokeless tobacco | 0.461578 |
| tobacco leaf | 0.704021 |
| tobacco warehouses | 0.435441 |
|
CLICK HERE |
| 7614 |
Centers for Disease Control and Prevention |
Html |
en |
Multistate Fungal Meningitis Outbreak - Interim Guidance for Treatment |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| mmwrq@cdc.gov. | 0.564873 |
| endorsement | 0.464443 |
| Human Services | 0.643663 |
| assistive technology | 0.567224 |
| MMWR HTML versions | 0.657324 |
| U.S. Department | 0.640442 |
| electronic PDF version | 0.644109 |
| brown-black mold | 0.590032 |
| potentially contaminated product | 0.790199 |
| possible fungal infections | 0.771168 |
| expert opinion | 0.53961 |
| Additional information | 0.543921 |
| Contact GPO | 0.566238 |
| intra-articular injections | 0.603814 |
| commercial sources | 0.540745 |
| current prices | 0.535924 |
| New England Compounding | 0.675567 |
| original paper copy | 0.638799 |
| steroid products | 0.703913 |
| original MMWR paper | 0.652073 |
| U.S. Government Printing | 0.643522 |
| multistate meningitis outbreak | 0.728306 |
| Drug Administration | 0.553252 |
| spinal area | 0.548143 |
|
| empiric antifungal therapy | 0.688724 |
| parameningeal infections | 0.604824 |
| MMWR readers | 0.547669 |
| character translation | 0.533452 |
| adult patients | 0.642288 |
| format errors | 0.535082 |
| Exserohilum rostratum | 0.562469 |
| septic arthritis | 0.541861 |
| steroid injection | 0.625629 |
| Aspergillus species | 0.570674 |
| subject line | 0.554388 |
| typeset documents | 0.541868 |
| trade names | 0.540848 |
| CDC interim guidance | 0.906949 |
| official text | 0.53173 |
| predominant pathogen | 0.559382 |
| local public health | 0.685796 |
| peripheral joint space | 0.675992 |
| non-CDC sites | 0.539627 |
| brown-black molds | 0.590025 |
| NECC | 0.546997 |
| steroid medication | 0.622976 |
| investigation | 0.473003 |
| electronic conversions | 0.531471 |
|
CLICK HERE |
| 7769 |
Centers for Disease Control and Prevention |
Html |
en |
CDCynergy Lite - Implementation |
Gateway to Health Communication and Social Marketing Practice - CDCynergy Lite, implementation |
| brief summaries | 0.761091 |
| smooth communication | 0.757612 |
| news event | 0.79635 |
| new staff | 0.78824 |
| program | 0.971754 |
| vendor price analysis | 0.909547 |
| issue requests | 0.777145 |
| public launch | 0.806376 |
| evaluation data | 0.756074 |
| unexpected opportunities | 0.802497 |
| work | 0.656838 |
| motivational strategies | 0.76119 |
| program plan | 0.802821 |
| evaluation feedback | 0.756189 |
| program objectives | 0.793888 |
| program activities | 0.921944 |
| e-mail updates | 0.76053 |
| potential threats | 0.795049 |
| organizational clearance | 0.774232 |
| various formats | 0.754091 |
| messages | 0.663063 |
| staff meetings | 0.775518 |
| dissemination plan | 0.754937 |
| fair competition | 0.769335 |
| effective leadership style | 0.903978 |
|
| print materials | 0.783024 |
| prospective clients | 0.762233 |
| community leaders | 0.768028 |
| uniform report | 0.748699 |
| stakeholders | 0.670444 |
| target audience | 0.749794 |
| sample forms | 0.771002 |
| new ones | 0.773375 |
| sample RFP | 0.778989 |
| media attention | 0.763062 |
| low-key startup announcement | 0.917683 |
| necessary adjustments | 0.757764 |
| program monitoring | 0.786927 |
| program materials | 0.819985 |
| soft launch | 0.798704 |
| audience feedback | 0.751216 |
| staff | 0.797247 |
| overall program model | 0.915811 |
| web search | 0.773973 |
| ongoing clarification | 0.763894 |
| new circumstances | 0.759606 |
| detailed reports | 0.758896 |
| partners | 0.687848 |
| financial inputs | 0.761615 |
|
CLICK HERE |
| 10019 |
Centers for Disease Control and Prevention |
Html |
en |
Facebook Guidelines and Best Practices |
Basic information from CDC about breast cancer. |
| Facebook posts | 0.384817 |
| social networking site | 0.232782 |
| Social Media Council | 0.225729 |
| Digital Media Branch | 0.305516 |
| CDC’s National | 0.260218 |
| following best practices | 0.203041 |
| Facebook page administrators | 0.436719 |
| Facebook content | 0.369212 |
| Communication Science | 0.246286 |
| official comment policy | 0.221212 |
| Automatically delivered metrics | 0.204401 |
| Associate Director | 0.208639 |
| safety topics | 0.211585 |
| cdc facebook page | 0.901432 |
| main CDC Facebook | 0.483546 |
| CDC Facebook pages | 0.531611 |
| Health Communication Science | 0.225609 |
| social media activities | 0.224842 |
|
| main CDC profile | 0.314745 |
| social media tools | 0.318275 |
| CDC Brand Identity | 0.308815 |
| Electronic Media Branch | 0.229435 |
| social networking service | 0.236468 |
| page comment policy | 0.234256 |
| Facebook activities | 0.372091 |
| Facebook presence | 0.385301 |
| CDC logo | 0.258987 |
| CDC health | 0.267683 |
| health communications strategy | 0.218943 |
| Facebook comments | 0.347847 |
| example CDC Facebook | 0.521128 |
| CDC comment policy | 0.297329 |
| Facebook Insights | 0.360485 |
| best practices | 0.223299 |
| Metrics intranet site | 0.206274 |
|
CLICK HERE |
| 10653 |
Centers for Disease Control and Prevention |
Html |
en |
Chemical Agents'First Hours |
The CERC training program educates people on the principles and application of crisis and emergency risk communication when responding to a public health emergency. |
|
|
CLICK HERE |
| 11149 |
Centers for Disease Control and Prevention |
Html |
en |
B Virus | Resources and Publications | Herpes B | CDC |
Journal articles and publications about B virus and B virus infection. |
| public settings | 0.537687 |
| infectious disease issues | 0.480099 |
| herpesvirus B-seropositive macaques | 0.555841 |
| CDC. Notice | 0.477008 |
| CDC National Institute | 0.488123 |
| Section VIII—Agent Summary | 0.480243 |
| reports B virus | 0.486023 |
| Appl Occup Environ | 0.467717 |
| Infect Dis | 0.902955 |
| Epidemiologic notes | 0.479573 |
| State Public Health | 0.656326 |
| Herpesvirus simiae | 0.518985 |
| biomedical laboratories | 0.510377 |
| L. Cercopithecine herpesvirus | 0.558832 |
| ocular exposure | 0.521318 |
| reports B-virus infection | 0.489282 |
| Disease Control | 0.516055 |
| Working Group | 0.4742 |
| Engel GA | 0.467814 |
| Clin Infect Dis | 0.703537 |
| monkey B virus | 0.528933 |
| U.S. Public Health | 0.561178 |
| M. Fatal Infection | 0.477533 |
| National Institutes | 0.51479 |
|
| Fatal Cercopithecine herpesvirus | 0.567249 |
| venereal B virus | 0.479719 |
| occupational safety | 0.557786 |
| Chapman LE | 0.517858 |
| Public Health Veterinarians | 0.656169 |
| Human herpesvirus | 0.506575 |
| nonhuman primates | 0.477421 |
| National Research Council | 0.475511 |
| Hilliard JK | 0.671257 |
| Health Service guideline | 0.49005 |
| infectious Cercopithecine herpesvirus | 0.546547 |
| National Association | 0.540051 |
| J. B virus | 0.483794 |
| MMWR Recomm Rep | 0.743975 |
| Public Health Service | 0.561162 |
| pet macaque monkeys | 0.468904 |
| serial online | 0.582944 |
| Stewart JA | 0.524705 |
| et al | 0.602538 |
| Weigler BJ | 0.469783 |
| Cercopithecine herpesvirus | 0.652666 |
| Government Printing Office. | 0.631656 |
| Davenport DS | 0.571695 |
|
CLICK HERE |
| 11362 |
Centers for Disease Control and Prevention |
Html |
en |
Tools for Protecting Healthcare Personnel - HAI |
null |
| training healthcare personnel | 0.459529 |
| HICPAC Publications page | 0.379607 |
| current CDC guidance | 0.381456 |
| HIV-infected blood MMWR | 0.403685 |
| CDC Sharps Safety | 0.395744 |
| Health Promotion Update | 0.364661 |
| Healthcare Settings NIOSH | 0.433732 |
| healthcare infection control | 0.478697 |
| Occupational Blood Exposures | 0.588637 |
| personal protective equipment | 0.715078 |
| Invasive Procedures MMWR | 0.397473 |
| Preventing Percutaneous Injuries | 0.508864 |
| healthcare epidemiologists | 0.373511 |
| postexposure prophylaxis | 0.799098 |
| acute-care hospital settings | 0.371578 |
| human immunodeficiency virus | 0.907375 |
| Postexposure Prophylaxis Infection | 0.531491 |
| bloodborne pathogens | 0.490321 |
| Healthcare settings MMWR | 0.466727 |
| healthcare personnel | 0.631102 |
| healthcare providers | 0.369415 |
| Hepatitis B Virus | 0.431211 |
| Clinicians Post-Exposure Prophylaxis | 0.432017 |
| Appendix B. Management | 0.391378 |
| infection control | 0.742266 |
|
| HIV testing services | 0.414676 |
| Bloodborne Pathogens MMWR | 0.42949 |
| HIV Postexposure Prophylaxis | 0.557119 |
| protective equipment PPE | 0.417971 |
| Ebola Virus Disease | 0.439641 |
| occupational HIV exposure | 0.620004 |
| Injuries Among Healthcare | 0.379813 |
| Health Service Guidelines | 0.65792 |
| Postexposure Prophylaxis MMWR | 0.539142 |
| infection control programs | 0.432286 |
| HIV transmission | 0.367964 |
| U.S. Public Health | 0.49618 |
| Hospital Epidemiology Vol. | 0.369738 |
| occupational exposures | 0.593338 |
| Healthcare Personnel Need | 0.447976 |
| Health Omnibus Programs | 0.371508 |
| Healthcare Workers | 0.382139 |
| Appendix C. Basic | 0.375231 |
| infection control staff | 0.433037 |
| A. Practice Recommendations | 0.386598 |
| Public Health Service | 0.660893 |
| Blood Exposures MMWR | 0.454179 |
| healthcare work environment | 0.460543 |
| healthcare settings | 0.561254 |
|
CLICK HERE |